Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 18, 2005Biochemistry

Specific Targeting of Hepatitis C Virus NS3 RNA Helicase. Discovery of the Potent and Selective Competitive Nucleotide-Mimicking Inhibitor QU663

View Full Paper
Ask AI
Bookmark
Share

Authors

GMGiovanni MagaIstituto di Genetica MolecolareSGSandra GemmaUniversity of SienaCFCaterina FattorussoUniversity of Naples Federico II

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Maga et al. (2005) studied this question.

synapsesocial.com/papers/6a5efff25fa505cbb7602b8bhttps://doi.org/10.1021/bi047437u
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1New therapeutic strategies for hepatitis C2002 · 154 citations
  2. 2Quinoxalinylethylpyridylthioureas (QXPTs) as Potent Non-Nucleoside HIV-1 Reverse Transcriptase (RT) Inhibitors. Further SAR Studies and Identification of a Novel Orally Bioavailable Hydrazine-Based Antiviral Agent2001 · 95 citations
  3. 3Potentiation of Inhibition of Wild-Type and Mutant Human Immunodeficiency Virus Type 1 Reverse Transcriptases by Combinations of Nonnucleoside Inhibitors and<scp>d</scp>- and<scp>l</scp>-(β)-Dideoxynucleoside Triphosphate Analogs2001 · 11 citations
  4. 4The Stereoselective Targeting of a Specific Enzyme-Substrate Complex Is the Molecular Mechanism for the Synergic Inhibition of HIV-1 Reverse Transcriptase by (R)-(−)-PPO4642001 · 11 citations